Workpath Announces 105% Customer Count Growth from Q1 to Q2; Annual Revenue Growth of 50%
On-Demand Mobile Healthcare Workforce Dispatch Platform Attributes Growth To the Return of the House Call
Workpath, the only on-demand dispatch and scheduling tech for mobile healthcare teams, is proud to announce a 105% increase in the company’s customer count and a 50% increase in revenue from Q1 to Q2 2020. Platform usage has surged as well. Weekly appointment volume increased 165% since January when the first COVID-19 case was reported in the U.S. Since the launch of the platform in 2018, company revenue has grown 915% and more than 85,000 patients have received care dispatched through Workpath.
HR Technology News: Minimize the Number of Regular Meetings with Virtual Stand-ups
New Workpath customers include mobile phlebotomy businesses (i.e. blood draws), mobile diagnostic imaging companies (e.g. ultrasounds), and in-home urgent care providers, among others. They join a customer list that includes clinical trial operators, a Fortune 10 company providing at-home care, two of the three largest diagnostic lab businesses in the U.S., and Siemens Healthineers.
Workpath’s HIPAA-compliant tech revives the traditional house call. It saves hours of back-office work by instantly matching and dispatching a healthcare provider’s qualified, available, and nearby professionals to a patient’s home or workplace. It provides updates in real-time to patients awaiting a healthcare professional’s arrival through mobile phone alerts, much like the experience of hailing a driver with a ride-sharing app. And it ensures compliance with built-in checklists and integrations to electronic health record systems (EHRs).
HR Technology News: Still Here & Still Remote: Supporting Your People in a COVID-19 World
Workpath’s CEO Eddie Peloke attributes the company’s growth to a combination of pandemic-induced shutdowns and the limitations of telehealth. Patients – especially vulnerable populations like elderly or immuno-compromised patients – are avoiding clinics and hospitals out of fear of being infected with COVID-19. In turn, telehealth usage has exploded, but it has its limitations. According to the CDC, 70% of medical decisions require blood tests (or other tests dependent on the collection and analysis of a biological specimen).
HR Technology News: Smartsheet Brings Together Government Industry Experts to Form Federal Advisory Board